比索洛尔对充血性心衰患者CGRP和ET1浓度及心脏功能的影响
心力衰竭,,比索洛尔;心力衰竭,充血性;降钙素基因相关肽;内皮素1;心脏射血分数,0引言,1材料和方法,2结果,3讨论,【参考文
(第四军医大学西京医院: 心血管内科, 综合诊疗科心电图室,陕西 西安 710033)Effects of bisoprolol on plasma calcitonin gene related peptide, endothlin and heart function in patients with chronic heart failure
WANG HaiYan, JIA GuoLiang, GUO WenYi, HE Zheng, ZHANG Qing, ZHENG XiaoRong
Department of Cardiovasology, Polyclinic, Xijing Hospital, Fourth Military Medical University, Xian 710033, China
【Abstract】 AIM: To study the effects of bisoprolol on plasma calcitonin gene related peptide (CGRP), endothelin (ET)1 levels and heart functions in patients with chronic heart failure.METHODS: Sixtyeight patients with chronic heart failure were divided into two groups: the bisoprolol group and the control group. Blood samples were drawn from median cubital veins of all these patients at the beginning of the study and followup after the 7month. The plasma concentration of ET1 and CGRP were detected by radioimmunoassay, and the left ventricular ejection fraction (EF%) were recorded to evaluate the effects of bisoprolol.RESULTS: At the end of 7month follow up, the plasma concentrations of ET1 and CGRP in bisoprolol group decreased significantly compared with those at the beginning of the study (P<0.01) and it was also true compared with those of the control group (P<0.01).The values of EF% were higher in both groups after 7month followup, and the values of EF% was significantly higher in the bisoprolol group than those in the control group (all P<0.01). CONCLUSION: Bisoprolol added to other routine drugs can decrease the levels of the plasma CGRP and ET1 and improve the heart functions of patients with heart failure. ......
您现在查看是摘要页,全文长 11297 字符。